Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Bayer symbol

Bayer agrees $2.9bn deal for Algeta to get Xofigo control

Raises initial offer to buy Norweigan pharma company

Merck turns to gamification in diabetes

Working with Ayogo on mobile app to improve adherence

- PMLiVE

GSK’s Anoro first LAMA/LABA approved for COPD in US

Important step towards eventually replacing Seretide/Advair sales

- PMLiVE

AstraZeneca buys BMS out of diabetes alliance

Will spend up to $4.3bn to secure sole rights to Onglyza and Forxiga

- PMLiVE

Digitas appoints Michael Leis

Move backs up its social strategy drive

WPP buys into strategic consultants RAA

Firm also runs symposia in healthcare and other sectors

Datateam expands its med comms presence

Acquires PMLiVE publisher PMGroup

- PMLiVE

AZ faces early competition to Nexium in the US

Korea's Hanmi and Amneal Pharmaceuticals launches first generic rival

- PMLiVE

Endo builds pain management business

Agrees $105m deal to acquire NuPathe

- PMLiVE

Almirall expands in US via $400m deal to buy Aqua

Will boost its standing in dermatology

- PMLiVE

Amgen throws its hat into the cholesterol antibody ring

Evolocumab set for a race to market with Sanofi/Regeneron and Pfizer

Versartis names chief financial officer

Joshua Brumm joins from Pharmacyclics

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links